Lipoprotein secretion and triglyceride stores in the heart

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Molecular Cardiology

Background:

• Apolipoprotein B and microsomal triglyceride transfer protein genes are expressed in heart tissue, but their function is unclear.
• The heart's role in lipoprotein assembly and secretion has not been well understood.

Purpose of the Study:

• To investigate the functional significance of lipoprotein assembly genes in the heart.
• To determine if the heart secretes lipoproteins and how this process impacts cardiac lipid metabolism.

Main Methods:

• Utilized mouse models with altered expression of apolipoprotein B and microsomal triglyceride transfer protein.
• Examined triglyceride secretion and storage in the heart under various genetic conditions.
• Investigated the impact of blocking lipoprotein secretion on cardiac lipid accumulation.

Main Results:

• Demonstrated that the beating mouse heart secretes spherical lipoproteins.
• Increased cardiac lipoprotein production correlated with enhanced triglyceride secretion and reduced cardiac triglyceride stores.
• Blocking heart lipoprotein secretion led to increased cardiac triglyceride accumulation.
• Enhanced lipoprotein production protected against pathological lipid accumulation in a mouse model.

Conclusions:

• Heart-derived lipoprotein secretion plays a crucial role in regulating cardiac triglyceride homeostasis.
• This process may serve as a protective mechanism against detrimental effects of excess lipids in the heart.